Research square · 2026
Xpert Ultra on nasopharyngeal swabs detects one-third of pulmonary tuberculosis: a nested case-control study in South African primary care.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nakawunde Robinah, Achar Jay, Allwood Brian, Moodley Suventha, Rockman Loren, Okunola Anna, Naidoo Daphne, Banaei Niaz, Marsh Charissa C, Theron Grant
Аннотация
BACKGROUND: Sputum-free alternatives for tuberculosis (TB) diagnosis are a public health priority. Nasopharyngeal swabs (NPSs), a specimen routinely used for viral testing especially at-scale in outbreak investigations, may have promise but has not been evaluated in people investigated for TB.
METHODS: We evaluated Xpert MTB/RIF Ultra (Ultra; Cepheid, Sunnyvale, California, USA) on stored NPSs (NPSU) from adults with presumptive TB consecutively presenting to primary care in Cape Town, South Africa. Using a nested case-control design, all participants with TB had a NPS tested (n = 148) and people without TB (n = 117) were randomly selected matched by HIV status. We used a microbiological (MRS) and extended microbiological reference standards (eMRS). A subset of convenience-sampled casescontrols also received flocked tongue swab Ultra (TSU) (n = 57 cases, n = 66 controls).
RESULTS: Twenty-one (8%) of NPSUs were unsuccessful (all errors). NPSU sensitivity was 35% (95% CI 27, 43), specificity 88% (80, 93). Sensitivity was lower in HIV-positive participants [24% (14, 36) vs. 44% (32, 56)]. TSU had higher sensitivity [67% (53, 79) vs. 28% (17, 42) in the head-to-head comparison, detecting 22 additional cases] than NPSU. Specificity was comparable.
CONCLUSION: NPSU sensitivity (35%) was lower than TSU and below the WHO target of 80% for non-sputum confirmatory tests; specificity (88%) was also below the 98% target. NPSs may have utility if already collected in mass testing campaigns for other diseases but unless performance can be optimized (e.g., by using purpose-built swab platforms) do not appear useful for TB diagnosis.
METHODS: We evaluated Xpert MTB/RIF Ultra (Ultra; Cepheid, Sunnyvale, California, USA) on stored NPSs (NPSU) from adults with presumptive TB consecutively presenting to primary care in Cape Town, South Africa. Using a nested case-control design, all participants with TB had a NPS tested (n = 148) and people without TB (n = 117) were randomly selected matched by HIV status. We used a microbiological (MRS) and extended microbiological reference standards (eMRS). A subset of convenience-sampled casescontrols also received flocked tongue swab Ultra (TSU) (n = 57 cases, n = 66 controls).
RESULTS: Twenty-one (8%) of NPSUs were unsuccessful (all errors). NPSU sensitivity was 35% (95% CI 27, 43), specificity 88% (80, 93). Sensitivity was lower in HIV-positive participants [24% (14, 36) vs. 44% (32, 56)]. TSU had higher sensitivity [67% (53, 79) vs. 28% (17, 42) in the head-to-head comparison, detecting 22 additional cases] than NPSU. Specificity was comparable.
CONCLUSION: NPSU sensitivity (35%) was lower than TSU and below the WHO target of 80% for non-sputum confirmatory tests; specificity (88%) was also below the 98% target. NPSs may have utility if already collected in mass testing campaigns for other diseases but unless performance can be optimized (e.g., by using purpose-built swab platforms) do not appear useful for TB diagnosis.